Premium
Response to Doxorubicin in Hairy Cell Leukaemia
Author(s) -
McCarthy D.,
Catovsky D.
Publication year - 1978
Publication title -
scandinavian journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 84
eISSN - 1600-0609
pISSN - 0036-553X
DOI - 10.1111/j.1600-0609.1978.tb00392.x
Subject(s) - doxorubicin , cancer research , medicine , chemotherapy
A case of hairy cell leukaemia (HCL) treated by single‐agent chemotherapy after the failure of splenectomy is reported. The patient was treated with doxorubicin 50 mg on 4 occasions over an 8‐day period. After 2 weeks of profound pancytopenia, substantial blood and bone marrow improvement ensued. This case demonstrates that HCL may in some cases be treated successfully by intensive chemotherapy.